GT Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
GT Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2012 to Q3 2024.
  • GT Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 2.23M shares, a 63.4% increase year-over-year.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.35M shares, a 26.9% increase from 2022.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.06M shares, a 96.2% decline from 2021.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 28.2M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 2.23M +867K +63.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.71M +373K +27.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.38M +298K +27.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.35M +285K +26.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 1.37M -30M -95.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 1.34M -29.9M -95.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.08M -31.4M -96.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 1.06M -27.1M -96.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 31.4M -648 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 31.2M -2.28M -6.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 32.5M +16.2M +100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 28.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 31.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-31
Q2 2021 33.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 16.2M -53.8M -76.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 70.1M +19M +37.2% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q1 2019 51.1M +975K +1.95% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 50.2K -16.7M -99.7% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-29
Q3 2018 50.2M +34.1M +213% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 -0.18* +4.96 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 50.1M +49.9M +26024% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 16.8M +16.7M +20486% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 16M -11.4M -41.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -5.14* -23.3M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 192K -17.2M -98.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 81.5K -2.31M -96.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 27.5M +25.1M +1044% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 23.3M +20.9M +874% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 17.4M +15M +631% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 2.39M Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 2.4M -588M -99.6% Jul 1, 2015 Sep 30, 2015 10-Q/A 2018-02-28
Q2 2015 2.4M -571M -99.6% Apr 1, 2015 Jun 30, 2015 10-Q/A 2018-02-28
Q1 2015 2.38M -571M -99.6% Jan 1, 2015 Mar 31, 2015 10-Q/A 2018-02-28
Q3 2014 590M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 573M 0 0% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 573M +25.8M +4.72% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q2 2013 573M +244M +74% Apr 1, 2013 Jun 30, 2013 10-Q 2015-01-08
Q1 2013 547M +264M +93.4% Jan 1, 2013 Mar 31, 2013 10-Q 2015-01-08
Q2 2012 329M Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-12
Q1 2012 283M Jan 1, 2012 Mar 31, 2012 10-Q 2014-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.